Daniel S. Sundheim's Net Worth
$1.26 Billion
Who is Daniel S. Sundheim?
Daniel S. Sundheim has an estimated net worth of $1.26 Billion. This is based on reported shares across multiple companies, which include Maplebear Inc., Editas Medicine, Inc., Arbutus Biopharma Corp, Myovant Sciences Ltd., Wayfair Inc., Sight Sciences, Inc., Outset Medical, Inc., Warby Parker Inc., Finance of America Companies Inc., Axovant Sciences Ltd., and FIRST DATA CORP.
SEC CIK
Daniel S. Sundheim's CIK is 0001621588
Past Insider Trading and Trends
2015 was Daniel S. Sundheim's most active year for acquiring shares with 18 total transactions. Daniel S. Sundheim's most active month to acquire stocks was the month of January. 2021 was Daniel S. Sundheim's most active year for disposing of shares, totalling 17 transactions. Daniel S. Sundheim's most active month to dispose stocks was the month of April. 2021 saw Daniel S. Sundheim paying a total of $184,997,804.72 for 9,052,977 shares, this is the most they've acquired in one year. In 2021 Daniel S. Sundheim cashed out on 6,326,018 shares for a total of $17,996,717.05, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
FIRST DATA CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 43.5M |
—
|
—
| 43.5M |
Apr 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Editas Medicine, Inc. (EDIT) Snapshot price: $7.14
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 4
|
∞
| 5.46M |
—
|
—
| 5.46M |
Feb 8 - Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Arbutus Biopharma Corp (ABUS) Snapshot price: $2.5099
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Myovant Sciences Ltd. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Axovant Sciences Ltd. (SIOX) Snapshot price: $0.475
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||